X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs NATCO PHARMA - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA NATCO PHARMA SANOFI INDIA/
NATCO PHARMA
 
P/E (TTM) x 32.8 30.7 106.9% View Chart
P/BV x 6.3 23.3 26.9% View Chart
Dividend Yield % 1.4 0.5 293.3%  

Financials

 SANOFI INDIA   NATCO PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
NATCO PHARMA
Mar-14
SANOFI INDIA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs4,560877 520.0%   
Low Rs4,400424 1,039.0%   
Sales per share (Unadj.) Rs1,028.5223.4 460.3%  
Earnings per share (Unadj.) Rs129.031.1 415.1%  
Cash flow per share (Unadj.) Rs186.040.3 461.8%  
Dividends per share (Unadj.) Rs68.005.00 1,360.0%  
Dividend yield (eoy) %1.50.8 197.4%  
Book value per share (Unadj.) Rs753.6219.5 343.3%  
Shares outstanding (eoy) m23.0333.07 69.6%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x4.42.9 149.7%   
Avg P/E ratio x34.720.9 166.0%  
P/CF ratio (eoy) x24.116.1 149.2%  
Price / Book Value ratio x5.93.0 200.7%  
Dividend payout %52.716.1 327.6%   
Avg Mkt Cap Rs m103,17421,504 479.8%   
No. of employees `0003.6NA-   
Total wages/salary Rs m3,5921,128 318.5%   
Avg. sales/employee Rs Th6,537.7NM-  
Avg. wages/employee Rs Th991.4NM-  
Avg. net profit/employee Rs Th819.8NM-  
INCOME DATA
Net Sales Rs m23,6867,389 320.6%  
Other income Rs m708167 423.7%   
Total revenues Rs m24,3947,556 322.8%   
Gross profit Rs m5,2811,793 294.5%  
Depreciation Rs m1,313304 431.3%   
Interest Rs m15366 4.1%   
Profit before tax Rs m4,6611,290 361.4%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,691309 547.8%   
Profit after tax Rs m2,9701,027 289.1%  
Gross profit margin %22.324.3 91.9%  
Effective tax rate %36.323.9 151.6%   
Net profit margin %12.513.9 90.2%  
BALANCE SHEET DATA
Current assets Rs m15,6733,681 425.7%   
Current liabilities Rs m6,6783,123 213.8%   
Net working cap to sales %38.07.6 502.4%  
Current ratio x2.31.2 199.1%  
Inventory Days Days7689 84.9%  
Debtors Days Days2259 38.0%  
Net fixed assets Rs m8,0987,685 105.4%   
Share capital Rs m230331 69.6%   
"Free" reserves Rs m17,0886,670 256.2%   
Net worth Rs m17,3567,259 239.1%   
Long term debt Rs m0955 0.0%   
Total assets Rs m25,40011,957 212.4%  
Interest coverage x311.74.5 6,893.5%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.90.6 150.9%   
Return on assets %11.811.7 100.8%  
Return on equity %17.114.2 120.9%  
Return on capital %26.920.7 130.0%  
Exports to sales %24.539.4 62.2%   
Imports to sales %28.05.7 490.8%   
Exports (fob) Rs m5,8012,908 199.5%   
Imports (cif) Rs m6,627421 1,573.4%   
Fx inflow Rs m7,1453,445 207.4%   
Fx outflow Rs m6,846703 974.1%   
Net fx Rs m2992,743 10.9%   
CASH FLOW
From Operations Rs m3,2261,440 224.0%  
From Investments Rs m-1,555-1,089 142.8%  
From Financial Activity Rs m-1,818-353 515.5%  
Net Cashflow Rs m-147-1 9,865.8%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 60.4 1.5 4,108.8%  
Indian inst/Mut Fund % 14.4 7.8 183.7%  
FIIs % 14.6 16.6 87.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 26.0 40.4%  
Shareholders   15,184 25,395 59.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  FULFORD INDIA  ALEMBIC PHARMA  AJANTA PHARMA  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Rally, IMF's GDP Prediction, and Top Stocks in Action(Pre-Open)

On Tuesday, share markets in India opened in green and ended on a positive note. The BSE Sensex closed higher by 342 points to close above 36,000 levels for the first time ever.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jan 23, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS